Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani.
The current business model on which biotech has relied is flawed. Due to poor rates of
return, investment has dried [...]
Fixing Biotech's Broken Business Model